300 related articles for article (PubMed ID: 3038500)
1. Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.
Campoli-Richards DM; Brogden RN
Drugs; 1987 Jun; 33(6):577-609. PubMed ID: 3038500
[TBL] [Abstract][Full Text] [Related]
2. Sultamicillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Friedel HA; Campoli-Richards DM; Goa KL
Drugs; 1989 Apr; 37(4):491-522. PubMed ID: 2661196
[TBL] [Abstract][Full Text] [Related]
3. Sulbactam plus ampicillin: interim review of efficacy and safety for therapeutic and prophylactic use.
Lees L; Milson JA; Knirsch AK; Greenhalgh K
Rev Infect Dis; 1986; 8 Suppl 5():S644-50. PubMed ID: 3026019
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy and safety of sulbactam/ampicillin in patients suffering from chronic liver disease.
Galante D; Esposito S; Barba D; Ruffilli MP
J Antimicrob Chemother; 1987 Apr; 19(4):527-32. PubMed ID: 3034850
[TBL] [Abstract][Full Text] [Related]
5. Sulbactam/ampicillin for treatment of polymicrobial pelvic infections.
Hemsell DL
Drugs; 1986; 31 Suppl 2():22-5. PubMed ID: 3013569
[TBL] [Abstract][Full Text] [Related]
6. Worldwide clinical experience with sultamicillin.
Pitts NE; Gilbert GS; Knirsch AK; Noguchi Y
APMIS Suppl; 1989; 5():23-34. PubMed ID: 2660868
[TBL] [Abstract][Full Text] [Related]
7. Sulbactam: biochemical factors involved in its synergy with ampicillin.
Labia R; Morand A; Lelievre V; Mattioni D; Kazmierczak A
Rev Infect Dis; 1986; 8 Suppl 5():S496-502. PubMed ID: 3025996
[TBL] [Abstract][Full Text] [Related]
8. Sulbactam/ampicillin, a new beta-lactamase inhibitor/beta-lactam antibiotic combination.
Benson JM; Nahata MC
Drug Intell Clin Pharm; 1988; 22(7-8):534-41. PubMed ID: 3046887
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity of ampicillin alone and in combination with sulbactam correlated with beta-lactamase production.
Chao HP; Ho SW; Luh KT; Hsieh WC
Taiwan Yi Xue Hui Za Zhi; 1987 Mar; 86(3):241-7. PubMed ID: 3037003
[No Abstract] [Full Text] [Related]
10. Two regimens of sultamicillin in treating uncomplicated gonorrhoea.
Farthing C; Thin RN; Smith S; Phillips I
Genitourin Med; 1985 Feb; 61(1):44-7. PubMed ID: 3002961
[TBL] [Abstract][Full Text] [Related]
11. Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections.
Betrosian AP; Douzinas EE
Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1099-112. PubMed ID: 19621991
[TBL] [Abstract][Full Text] [Related]
12. Ampicillin/sulbactam: current status in severe bacterial infections.
Rafailidis PI; Ioannidou EN; Falagas ME
Drugs; 2007; 67(13):1829-49. PubMed ID: 17722953
[TBL] [Abstract][Full Text] [Related]
13. Microbiological properties of sulbactam combined with ampicillin.
Barba D; Galante D; Esposito S; Ruffilli MP
Chemioterapia; 1987 Apr; 6(2):88-94. PubMed ID: 3036381
[TBL] [Abstract][Full Text] [Related]
14. Sulbactam/ampicillin: in vitro spectrum, potency, and activity in models of acute infection.
Retsema JA; English AR; Girard A; Lynch JE; Anderson M; Brennan L; Cimochowski C; Faiella J; Norcia W; Sawyer P
Rev Infect Dis; 1986; 8 Suppl 5():S528-34. PubMed ID: 3026001
[TBL] [Abstract][Full Text] [Related]
15. A non-comparative study of parenteral ampicillin and sulbactam in intra-thoracic and intra-abdominal infections.
Mehtar S; Croft RJ; Hilas A
J Antimicrob Chemother; 1986 Mar; 17(3):389-96. PubMed ID: 3009384
[TBL] [Abstract][Full Text] [Related]
16. The parenteral kinetics of ampicillin/sulbactam in man.
Foulds G; Knirsch AK; Stankewich JP; Weidler DR
Int J Clin Pharmacol Res; 1985; 5(2):79-86. PubMed ID: 2991150
[TBL] [Abstract][Full Text] [Related]
17. Beta-lactamase inhibitors from laboratory to clinic.
Bush K
Clin Microbiol Rev; 1988 Jan; 1(1):109-23. PubMed ID: 3060240
[TBL] [Abstract][Full Text] [Related]
18. Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Richards DM; Heel RC
Drugs; 1985 Apr; 29(4):281-329. PubMed ID: 3888599
[TBL] [Abstract][Full Text] [Related]
19. Use of ampicillin/sulbactam and sultamicillin in pediatric infections: a re-evaluation.
Dajani A
J Int Med Res; 2001; 29(4):257-69. PubMed ID: 11675898
[TBL] [Abstract][Full Text] [Related]
20. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Nomura S; Hanaki H; Nagayama A
J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
